These results were consistent with previous studies that HNRNPA2B1 promotes tumor progress through regulating EMT in colorectal cancer (CRC) (42), breast cancer (48), and pancreatic cancer (49). This evidence concerns the gene HNRNPA2B1 and familial pancreatic carcinoma.